These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 24444256

  • 1. Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy.
    Lionetti V, Matteucci M, Ribezzo M, Di Silvestre D, Brambilla F, Agostini S, Mauri P, Padeletti L, Pingitore A, Delsedime L, Rinaldi M, Recchia FA, Pucci A.
    J Cell Mol Med; 2014 Mar; 18(3):396-414. PubMed ID: 24444256
    [Abstract] [Full Text] [Related]

  • 2. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L, Tatou E, Vergely C, Maupoil V, Bouchot O, Mossiat C, Jazayeri S, Benkhadra S, Brenot R, Girard C, David M.
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [Abstract] [Full Text] [Related]

  • 3. Characterization of inwardly rectifying K+ channel in human cardiac myocytes. Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy.
    Koumi S, Backer CL, Arentzen CE.
    Circulation; 1995 Jul 15; 92(2):164-74. PubMed ID: 7600647
    [Abstract] [Full Text] [Related]

  • 4. The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy.
    Karch R, Neumann F, Ullrich R, Neumüller J, Podesser BK, Neumann M, Schreiner W.
    Cardiovasc Pathol; 2005 Jul 15; 14(3):135-44. PubMed ID: 15914298
    [Abstract] [Full Text] [Related]

  • 5. Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue.
    Roselló-Lletí E, Alonso J, Cortés R, Almenar L, Martínez-Dolz L, Sánchez-Lázaro I, Lago F, Azorín I, Juanatey JR, Portolés M, Rivera M.
    J Cell Mol Med; 2012 Oct 15; 16(10):2471-86. PubMed ID: 22435364
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical study of remodeling of myocardial lymphatic and blood microvascular structures in terminal heart failure: differences between ischemic and dilated cardiomyopathy.
    Dashkevich A, Bloch W, Antonyan A, Goebel H, Fries JU, Schlensak C, Beyersdorf F, Geissler HJ.
    Lymphology; 2010 Sep 15; 43(3):110-7. PubMed ID: 21226413
    [Abstract] [Full Text] [Related]

  • 7. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation.
    Parodi O, De Maria R, Oltrona L, Testa R, Sambuceti G, Roghi A, Merli M, Belingheri L, Accinni R, Spinelli F.
    Circulation; 1993 Aug 15; 88(2):509-22. PubMed ID: 8339413
    [Abstract] [Full Text] [Related]

  • 8. Alterations in left ventricular curvature and principal strains in dilated cardiomyopathy with functional mitral regurgitation.
    Tibayan FA, Lai DT, Timek TA, Dagum P, Liang D, Zasio MK, Daughters GT, Miller DC, Ingels NB.
    J Heart Valve Dis; 2003 May 15; 12(3):292-9. PubMed ID: 12803327
    [Abstract] [Full Text] [Related]

  • 9. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
    Ishimaru K, Miyagawa S, Fukushima S, Saito A, Sakai Y, Ueno T, Sawa Y.
    J Thorac Cardiovasc Surg; 2013 Dec 15; 146(6):1516-25. PubMed ID: 24229503
    [Abstract] [Full Text] [Related]

  • 10. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
    Sugiki T, Naya M, Manabe O, Wakasa S, Kubota S, Chiba S, Iwano H, Yamada S, Yoshinaga K, Tamaki N, Tsutsui H, Matsui Y.
    JACC Cardiovasc Imaging; 2011 Jul 15; 4(7):762-70. PubMed ID: 21757167
    [Abstract] [Full Text] [Related]

  • 11. Myocardial segmental thickness variability on echocardiography is a highly sensitive and specific marker to distinguish ischemic and non-ischemic dilated cardiomyopathy in new onset heart failure.
    Katikireddy CK, Acharya T.
    Int J Cardiovasc Imaging; 2019 May 15; 35(5):791-798. PubMed ID: 30594979
    [Abstract] [Full Text] [Related]

  • 12. Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: endothelin-1 system in the human failing heart.
    Serneri GG, Cecioni I, Vanni S, Paniccia R, Bandinelli B, Vetere A, Janming X, Bertolozzi I, Boddi M, Lisi GF, Sani G, Modesti PA.
    Circ Res; 2000 Mar 03; 86(4):377-85. PubMed ID: 10700441
    [Abstract] [Full Text] [Related]

  • 13. Identification of new biophysical markers for pathological ventricular remodelling in tachycardia-induced dilated cardiomyopathy.
    Benitez-Amaro A, Samouillan V, Jorge E, Dandurand J, Nasarre L, de Gonzalo-Calvo D, Bornachea O, Amoros-Figueras G, Lacabanne C, Vilades D, Leta R, Carreras F, Gallardo A, Lerma E, Cinca J, Guerra JM, Llorente-Cortés V.
    J Cell Mol Med; 2018 Sep 03; 22(9):4197-4208. PubMed ID: 29921039
    [Abstract] [Full Text] [Related]

  • 14. Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy.
    Flesch M, Schwinger RH, Schnabel P, Schiffer F, van Gelder I, Bavendiek U, Südkamp M, Kuhn-Regnier F, Böhm M.
    J Mol Med (Berl); 1996 Jun 03; 74(6):321-32. PubMed ID: 8862513
    [Abstract] [Full Text] [Related]

  • 15. Integrative Proteomic Analysis Reveals the Cytoskeleton Regulation and Mitophagy Difference Between Ischemic Cardiomyopathy and Dilated Cardiomyopathy.
    Liu M, Zhai L, Yang Z, Li S, Liu T, Chen A, Wang L, Li Y, Li R, Li C, Tan M, Chen Z, Qian J.
    Mol Cell Proteomics; 2023 Dec 03; 22(12):100667. PubMed ID: 37852321
    [Abstract] [Full Text] [Related]

  • 16. [Nuclear changes and p62 expression in ischemic and dilated cardiomyopathy].
    Cortés R, Portolés M, Roselló-Lletí E, Martínez-Dolz L, Almenar L, Salvador A, Rivera M.
    Rev Esp Cardiol; 2007 Dec 03; 60(12):1319-23. PubMed ID: 18082099
    [Abstract] [Full Text] [Related]

  • 17. Differences in echocardiographic characteristics of functional mitral regurgitation in ischaemic versus idiopathic dilated cardiomyopathy: a pilot study.
    Papadopoulou K, Giannakoulas G, Karvounis H, Dalamanga E, Karamitsos T, Parcharidou D, Damvopoulou E, Efthimiadis GK, Styliadis I, Parcharidis G.
    Hellenic J Cardiol; 2009 Dec 03; 50(1):37-44. PubMed ID: 19196619
    [Abstract] [Full Text] [Related]

  • 18. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
    Tompkins BA, Rieger AC, Florea V, Banerjee MN, Natsumeda M, Nigh ED, Landin AM, Rodriguez GM, Hatzistergos KE, Schulman IH, Hare JM.
    J Am Heart Assoc; 2018 Jul 12; 7(14):. PubMed ID: 30005555
    [Abstract] [Full Text] [Related]

  • 19. Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure.
    Di Somma S, Di Benedetto MP, Salvatore G, Agozzino L, Ferranti F, Esposito S, La Dogana P, Scarano MI, Caputo G, Cotrufo M, Santo LD, de Divitiis O.
    Eur J Heart Fail; 2004 Jun 12; 6(4):389-98. PubMed ID: 15182762
    [Abstract] [Full Text] [Related]

  • 20. Myocardial wall thinning predicts transmural substrate in patients with scar-related ventricular tachycardia.
    Yamashita S, Sacher F, Hooks DA, Berte B, Sellal JM, Frontera A, Al Jefairi N, Komatsu Y, Amraoui S, Denis A, Derval N, Sermesant M, Laurent F, Montaudon M, Hocini M, Haïssaguerre M, Jaïs P, Cochet H.
    Heart Rhythm; 2017 Feb 12; 14(2):155-163. PubMed ID: 28104088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.